Vidcast:  https://youtu.be/7jhOt9TyQXs

 

CoVid patients who received even one dose of an FDA-approved CoVid vaccine within a month of their CoVid diagnosis are more than 5 times less likely than an unvaccinated person to develop multiple symptoms of the dreaded long CoVid.   Researchers at the Massachusetts health think tanks Arcadia and MITRE studied 1,065,626 CoVid patients.

 

Analysis of the vaccination histories and the occurrence of long CoVid symptoms in these patients showed the protective effects of CoVid vaccines.  While vaccination following the diagnosis of an active CoVid infection protects against long CoVid the best when completed within a month of infection diagnosis, vaccination prior to any diagnosed CoVid infection is the most effective reducing the likelihood of developing long CoVid nearly 9 fold.

 

Preventing long CoVid is yet another reason to be vaccinated against CoVid.  The vaccines are most effective protecting you against both CoVid and long CoVid if completed long before possible exposure to the virus.

 

https://www.medrxiv.org/content/10.1101/2021.11.17.21263608v1.full.pdf

 

#CoVid #longcovid #vaccine